Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) — The “Asia-Pacific Interventional Imaging Market: Analysis and Forecast, 2023-2033” report has been added to ResearchAndMarkets.com’s offering.
The Asia-Pacific interventional imaging market was valued at $1.11 billion in 2023 and is expected to reach $2.44 billion by the end of 2033, growing at a CAGR of 8.18% during the forecast period 2023-2033.
This expansion can be ascribed to rising demand for minimally invasive procedures, as well as increased use of new technology and the prevalence of chronic conditions. The market encompasses a variety of techniques, consumables, systems, and software designed for chronic disease diagnosis and treatment.
The Asia-Pacific interventional imaging market is critical to the evolution of imaging systems, especially in medical diagnostics and therapy. It allows for accurate diagnosis and early disease identification. This early discovery improves treatment outcomes and the prognosis of patients. Interventional imaging technology has transformed therapy and detection, resulting in breakthroughs and promised future developments.
How can this report add value to an organization?
Workflow/Innovation Strategy: The Asia-Pacific interventional imaging market (by offering) has been segmented into detailed segments, including different types of interventional imaging systems, namely X-ray, CT scanners, MRI systems, and ultrasound imaging systems. Moreover, the study provides the reader with a detailed understanding of the different applications of these products.
Competitive Strategy: Key players in the Asia-Pacific interventional imaging market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Asia-Pacific interventional imaging market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.
- Canon Inc.
- Shimadzu Corporation
- Terumo Corporation
- Trivitron Healthcare
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 116 |
| Forecast Period | 2023 – 2033 |
| Estimated Market Value (USD) in 2023 | $1.11 Billion |
| Forecasted Market Value (USD) by 2033 | $2.44 Billion |
| Compound Annual Growth Rate | 8.1% |
| Regions Covered | Asia Pacific |
Key Topics Covered:
1 Markets
1.1 Product Definition
1.2 Inclusion and Exclusion
1.3 Key Findings
2 Interventional Imaging Market: Overview
2.1 Market Introduction
2.2 Market Footprint and Growth Potential, $Billion, 2022-2033
2.3 Current and Future State of Interventional Imaging in Industry
3 Industry Outlook
3.1 Key Trends
3.2 Patent Analysis
3.2.1 Patent Analysis (by Year)
3.2.2 Patent Analysis (by Country)
3.3 COVID-19 Impact on Interventional Imaging Market
3.3.1 COVID-19 Impact: Current Scenario of the Market
3.3.2 Pre- and During-COVID-19 Impact Assessment
3.3.2.1 Pre-COVID-19
3.3.2.2 During-COVID-19
3.4 Regulatory Requirements
3.4.1 Regulatory and Legal Requirements and Framework in the U.S.
3.4.2 Regulatory and Legal Requirements and Framework in Europe
3.4.3 Regulatory and Legal Requirements and Framework in Asia-Pacific
3.4.3.1 China
3.4.3.2 Japan
3.4.3.3 India
3.4.3.4 Australia
3.5 Product Benchmarking
4 Interventional Imaging Market Dynamics
4.1 Impact Analysis
4.2 Market Drivers
4.2.1 Increasing Demand for Minimally Invasive Surgical Procedures
4.2.2 Technological Advancements in Surgical Procedures and Imaging Technologies
4.2.2.1 Rising Adoption of 4K Imaging Technologies
4.2.2.2 3D and 4D Imaging
4.2.3 Upsurge in Incidence of Chronic Diseases Leading to Growth in the Adoption of Interventional Imaging
4.2.3.1 Cardiovascular Diseases
4.2.3.2 Cancer
4.2.4 Increasing Adoption of Inorganic Growth Strategies in the Market
4.3 Market Restraints
4.3.1 Shortages of Skilled Professionals
4.3.2 Restrictive Reimbursement Landscape
4.3.3 High Cost of Interventional Imaging Systems
4.4 Market Opportunities
4.4.1 Integration of AI in Interventional Imaging
4.4.2 Collaboration with Hospitals, Clinics, and Other Healthcare Facilities for Development of Interventional Imaging Solutions
5 Interventional Imaging Market (by Region), ($Billion), 2022-2033
5.1 Overview
5.1 Asia-Pacific
5.1.1 Market Sizing and Forecast
5.1.1.1 Asia-Pacific Interventional Imaging Market (by Offering)
5.1.1.2 Asia-Pacific Interventional Imaging Market (by Application)
5.1.1.3 Asia-Pacific Interventional Imaging Market (by End User)
5.1.2 Japan
5.1.3 China
5.1.4 Australia
5.1.5 South Korea
5.1.6 India
5.1.7 Singapore
5.1.8 Rest-of-Asia-Pacific
5.1.8.1 Market Sizing and Forecast
5.1.8.1.1 Rest-of-Asia-Pacific Interventional Imaging Market (by Offering)
5.1.8.1.2 Rest-of-Asia-Pacific Interventional Imaging Market (by Application)
5.1.8.1.3 Rest-of-Asia-Pacific Interventional Imaging Market (by End User)
6 Company Profiles
6.1 Interventional Imaging Ecosystem Active Players
6.1.1 Canon Inc.
6.1.1.1 Role of Canon Inc. in the Interventional Imaging Market
6.1.1.2 Recent Developments
6.1.1.3 Analyst Perspective
6.1.2 FUJIFILM Holdings Corporation
6.1.3 Shimadzu Corporation
6.1.4 Terumo Corporation
6.1.5 Trivitron Healthcare
For more information about this report visit https://www.researchandmarkets.com/r/nljnj2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Asia-Pacific Interventional Imaging Market
